Procter & Gamble (NYSE:PG) PT Raised to $182.00 at Jefferies Financial Group

→ The asset beating inflation by 4x (From Colonial Metals) (Ad)

Procter & Gamble (NYSE:PG - Get Free Report) had its target price raised by equities research analysts at Jefferies Financial Group from $175.00 to $182.00 in a research report issued on Monday, Benzinga reports. The brokerage presently has a "buy" rating on the stock. Jefferies Financial Group's price target indicates a potential upside of 13.35% from the company's current price.

PG has been the topic of several other reports. Stifel Nicolaus raised their price target on Procter & Gamble from $155.00 to $157.00 and gave the stock a "hold" rating in a research report on Wednesday, January 24th. Truist Financial raised shares of Procter & Gamble from a "hold" rating to a "buy" rating and increased their price target for the company from $160.00 to $175.00 in a research report on Monday, March 11th. Royal Bank of Canada boosted their price objective on shares of Procter & Gamble from $156.00 to $157.00 and gave the company a "sector perform" rating in a research report on Wednesday, January 24th. The Goldman Sachs Group began coverage on shares of Procter & Gamble in a report on Friday, March 1st. They set a "neutral" rating and a $168.00 target price for the company. Finally, Deutsche Bank Aktiengesellschaft upped their price target on Procter & Gamble from $170.00 to $172.00 and gave the company a "buy" rating in a research report on Wednesday, April 3rd. Seven research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of "Moderate Buy" and an average price target of $168.76.


Read Our Latest Research Report on PG

Procter & Gamble Price Performance

Shares of Procter & Gamble stock traded up $2.42 during trading on Monday, hitting $160.56. The stock had a trading volume of 8,925,924 shares, compared to its average volume of 6,958,951. The firm has a market cap of $377.80 billion, a price-to-earnings ratio of 26.32, a P/E/G ratio of 3.19 and a beta of 0.44. The company has a current ratio of 0.69, a quick ratio of 0.48 and a debt-to-equity ratio of 0.48. The business's 50-day moving average is $159.14 and its 200 day moving average is $153.02. Procter & Gamble has a 12 month low of $141.45 and a 12 month high of $163.14.

Procter & Gamble (NYSE:PG - Get Free Report) last announced its earnings results on Friday, April 19th. The company reported $1.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.42 by $0.10. The company had revenue of $20.20 billion during the quarter, compared to analyst estimates of $20.43 billion. Procter & Gamble had a net margin of 18.00% and a return on equity of 33.77%. The firm's quarterly revenue was up .6% compared to the same quarter last year. During the same period in the previous year, the business earned $1.37 earnings per share. As a group, sell-side analysts anticipate that Procter & Gamble will post 6.53 earnings per share for the current year.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, CEO R. Alexandra Keith sold 776 shares of the firm's stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $158.11, for a total transaction of $122,693.36. Following the completion of the sale, the chief executive officer now directly owns 4,859 shares in the company, valued at approximately $768,256.49. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In related news, CEO Gary A. Coombe sold 22,000 shares of Procter & Gamble stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $161.32, for a total value of $3,549,040.00. Following the completion of the sale, the chief executive officer now directly owns 36,845 shares in the company, valued at approximately $5,943,835.40. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO R. Alexandra Keith sold 776 shares of the business's stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $158.11, for a total value of $122,693.36. Following the completion of the transaction, the chief executive officer now directly owns 4,859 shares of the company's stock, valued at approximately $768,256.49. The disclosure for this sale can be found here. Over the last three months, insiders have sold 279,063 shares of company stock valued at $43,187,745. Insiders own 0.17% of the company's stock.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Dfpg Investments LLC boosted its holdings in shares of Procter & Gamble by 1.7% in the fourth quarter. Dfpg Investments LLC now owns 24,892 shares of the company's stock worth $3,680,000 after buying an additional 424 shares during the last quarter. Garrett Wealth Advisory Group LLC grew its position in shares of Procter & Gamble by 6.3% during the 3rd quarter. Garrett Wealth Advisory Group LLC now owns 4,419 shares of the company's stock valued at $645,000 after acquiring an additional 260 shares during the period. N.E.W. Advisory Services LLC lifted its position in shares of Procter & Gamble by 14.6% during the 3rd quarter. N.E.W. Advisory Services LLC now owns 94,424 shares of the company's stock valued at $13,772,000 after buying an additional 12,016 shares in the last quarter. Charles Schwab Investment Management Inc. grew its stake in shares of Procter & Gamble by 0.8% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 16,003,260 shares of the company's stock valued at $2,298,184,000 after acquiring an additional 131,339 shares during the period. Finally, Miracle Mile Advisors LLC increased its holdings in Procter & Gamble by 105.5% in the 4th quarter. Miracle Mile Advisors LLC now owns 59,363 shares of the company's stock worth $8,699,000 after acquiring an additional 30,473 shares in the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Company Profile

(Get Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

See Also

Analyst Recommendations for Procter & Gamble (NYSE:PG)

Should you invest $1,000 in Procter & Gamble right now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2024 Cover

With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.

Get This Free Report

Featured Articles and Offers

Search Headlines: